The association of serotonin reuptake inhibitors and benzodiazepines with ictal central apnea
Autor: | Rita Martins, Lisa M. Bateman, Norma J. Hupp, M. R. Sandhya Rani, Ronald M. Harper, Rup K. Sainju, Jaison S. Hampson, Catherine Scott, Luke A. Allen, Kingman P. Strohl, Daniel Friedman, Jennifer A. Ogren, Orrin Devinsky, Beate Diehl, Samden D. Lhatoo, Anita Zaremba, Brian K. Gehlbach, Laura Vilella, Johnson P. Hampson, Nuria Lacuey, Stephan U. Schuele, George B. Richerson, Maromi Nei |
---|---|
Rok vydání: | 2019 |
Předmět: |
Serotonin reuptake inhibitors
Male SUDEP Central apnea Neurodegenerative Electroencephalography Hypoxemia Cohort Studies Behavioral Neuroscience Epilepsy Benzodiazepines 0302 clinical medicine 030212 general & internal medicine Oximetry Prospective Studies Sudden Unexpected Death in Epilepsy Hypoxia Lung Central medicine.diagnostic_test Ictal central apnea Middle Aged Sleep Apnea Central Neurology Anesthesia Neurological Breathing Serotonin Uptake Inhibitors Female medicine.symptom Selective Serotonin Reuptake Inhibitors Adult Sleep Apnea Adolescent Clinical Sciences Article 03 medical and health sciences Young Adult Clinical Research Seizures medicine Humans Ictal Aged Neurology & Neurosurgery business.industry Neurosciences medicine.disease Brain Disorders Pulse oximetry Good Health and Well Being Relative risk Neurology (clinical) business 030217 neurology & neurosurgery |
Zdroj: | Epilepsy Behav Epilepsy & behavior : E&B, vol 98, iss Pt A |
ISSN: | 1525-5069 |
Popis: | Objective Ictal (ICA) and postconvulsive central apnea (PCCA) have been implicated in sudden unexpected death in epilepsy (SUDEP) pathomechanisms. Previous studies suggest that serotonin reuptake inhibitors (SRIs) and benzodiazepines (BZDs) may influence breathing. The aim of this study was to investigate if chronic use of these drugs alters central apnea occurrence in patients with epilepsy. Methods Patients with epilepsy admitted to epilepsy monitoring units (EMUs) in nine centers participating in a SUDEP study were consented. Polygraphic physiological parameters were analyzed, including video-electroencephalography (VEEG), thoracoabdominal excursions, and pulse oximetry. Outpatient medication details were collected. Patients and seizures were divided into SRI, BZD, and control (no SRI or BZD) groups. Ictal central apnea and PCCA, hypoxemia, and electroclinical features were assessed for each group. Results Four hundred and seventy-six seizures were analyzed (204 patients). The relative risk (RR) for ICA in the SRI group was half that of the control group (p = 0.02). In the BZD group, ICA duration was significantly shorter than in the control group (p = 0.02), as was postictal generalized EEG suppression (PGES) duration (p = 0.021). Both SRI and BZD groups were associated with smaller seizure-associated oxygen desaturation (p = 0.009; p ≪ 0.001). Neither presence nor duration of PCCA was significantly associated with SRI or BZD (p ≫ 0.05). Conclusions Seizures in patients taking SRIs have lower occurrence of ICA, and patients on chronic treatment with BZDs have shorter ICA and PGES durations. Preventing or shortening ICA duration by using SRIs and/or BZD in patients with epilepsy may play a possible role in SUDEP risk reduction. |
Databáze: | OpenAIRE |
Externí odkaz: |